Table 5.

Eligibility criteria for review on morphological imaging modality.

Study characteristic	Inclusion criteria	Exclusion criteria
Patient population	Patients with liver metastases from neuroendocrine tumors	Children or adolescents (under the age of 18 years)
	Patients who underwent liver transplantation or palliative liver resection or nonsurgical treatment (peptide receptor radionuclide treatment, chemotherapy, biotherapy)
Study design	Randomized controlled trials (RCTs)	Case reports
	Prospective and retrospective comparative cohort studies	Editorials
	Noncomparative cohort studies	Reviews
	Case-control studies
	Case series
Reporting		Studies that do not report the diagnostic accuracy (first scientific question)
		Studies that do not report the assessment of resectability (second scientific question)
Test of interest	Computed tomography (CT)
	Magnetic resonance imaging (MRI)
	Ultrasound scanning